35 results
424B3
PRTG
Portage Biotech Inc
7 Nov 23
Prospectus supplement
4:50pm
patent protection for our products;
the recruitment or departure of key personnel;
market conditions in the pharmaceutical and biotechnology sectors
F-1
PRTG
Portage Biotech Inc
31 Oct 23
Registration statement (foreign)
4:05pm
or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our products;
the recruitment
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
, including patents, litigation matters and our ability to obtain patent protection for our products;
the recruitment or departure of key personnel
424B5
stfbsh
19 Aug 22
Prospectus supplement for primary offering
10:52am
SUPPL
5n2g3m9 7st6mxx
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
75qs1i3wmg9 nq
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B5
20f5mrm9eocn 9jtwk
8 Mar 21
Prospectus supplement for primary offering
5:03pm
F-3
ki8wur0x1xvob6ze
24 Feb 21
Shelf registration (foreign)
5:22pm
6-K
EX-99.1
wuo25pkdybgl70 qty1
28 May 20
Report of Foreign Private Issuer
12:19pm
6-K
5tqkahq cuic7
16 Apr 20
Report of Foreign Private Issuer
11:27am
6-K
EX-99.2
lbtsp2o4 igpdmixo
31 Dec 19
Consolidated Interim Financial Statements
10:03am
6-K
efrbemk cuqqst0
11 Jul 19
Report of Foreign Issuer
1:36pm
6-K
EX-99.1
5frfik5hzj6d0cu
19 Feb 19
Report of Foreign Private Issuer
10:37am